Federal Psychedelic Legislation

8 psychedelic policy bills tracked in Federal, covering Multiple, Psilocybin. Current status breakdown: In Committee (6), Died (1), Signed into Law (1).

Federal psychedelic bills
BillStateSubstanceTypeStatusSponsorLast action
HB9559 - IBOGAINE Act Initiating Biomedical Outcomes to Garner Advancements into Innovative Neuroplastogen Efficacy Act Federal Multiple Clinical Research In Committee Morgan Luttrell Jul 17, 2026
SB4031 - Innovative Therapies Centers of Excellence Act Federal Psilocybin Clinical Research In Committee Ruben Gallego Mar 9, 2026
HB7091 - Expanding Veterans’ Access to Emerging Treatments Act Federal Psilocybin Clinical Research In Committee Jack Bergman Feb 2, 2026
HB2623 - Innovative Therapies Centers of Excellence Act of 2025 Federal Psilocybin Clinical Research In Committee Luis Correa May 8, 2025
HB7347 - To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to report on whether the Secretary will include certain psychedelic drugs in the formulary of the Department of Veterans Affairs. Federal Psilocybin Study/Task Force Died Derrick Van Orden Sep 6, 2024
HB4242 - To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy. Federal Psilocybin Study/Task Force In Committee Dan Crenshaw Jun 23, 2023
HB3684 - Douglas Mike Day Psychedelic Therapy to Save Lives Act of 2023 Federal Psilocybin Clinical Research In Committee Dan Crenshaw May 25, 2023
Initiative 81 - Entheogenic Plant and Fungus Policy Act (Washington, DC) Federal Multiple Decriminalization Signed into Law Decriminalize Nature DC Mar 15, 2021

All states · Full psychedelic legislation tracker